Marc D. Ryser, Assistant Professor of Population Health Sciences and Instructor of Mathematics and Assistant Professor and Member of Duke Cancer Institute

Marc D. Ryser

For a detailed description of past and current research projects, please visit

Areas of Expertise: Clinical Decision Sciences and Epidemiology

Office Location:  299B Physics Bldg, 120 Science Drive, Durham, NC 27708
Email Address: send me a message
Web Page:

Teaching (Spring 2019):


Ph.D.McGill University (Canada)2011
MS (Physics)EPFL2006
BS (Physics)EPFL2004
Research Interests:

Please visit my personal site for information about me and my research


Bone and Bones • Bone Neoplasms • Bone Resorption • Chemotaxis • Computational Biology • Computer Simulation • Fractures, Bone • Gene Expression Profiling • Homeostasis • Meta-Analysis as Topic • Models, Biological • Osteoblasts • Osteoprotegerin • Parathyroid Hormone-Related Protein • RANK Ligand • Solubility • Time Factors

Recent Publications

  1. Ryser, MD; Gulati, R; Eisenberg, MC; Shen, Y; Hwang, ES; Etzioni, RB, Identification of the Fraction of Indolent Tumors and Associated Overdiagnosis in Breast Cancer Screening Trials., American Journal of Epidemiology, vol. 188 no. 1 (January, 2019), pp. 197-205 [doi]  [abs]
  2. Ryser, MD; Yu, M; Grady, W; Siegmund, K; Shibata, D, Epigenetic Heterogeneity in Human Colorectal Tumors Reveals Preferential Conservation And Evidence of Immune Surveillance., Scientific Reports, vol. 8 no. 1 (November, 2018), pp. 17292 [doi]  [abs]
  3. Ryser, MD; Min, B-H; Siegmund, KD; Shibata, D, Spatial mutation patterns as markers of early colorectal tumor cell mobility., Proceedings of the National Academy of Sciences of the United States of America, vol. 115 no. 22 (May, 2018), pp. 5774-5779 [doi]  [abs]
  4. Role of Preoperative Variables in Reducing the Rate of Occult Invasive Disease for Women Considering Active Surveillance for Ductal Carcinoma In Situ., Jama Surgery, vol. 153 no. 3 (March, 2018), pp. 290-291 [doi]
  5. Ryser, MD; Horton, JK; Hwang, ES, How Low Can We Go-and Should We? Risk Reduction for Minimal-Volume DCIS., Annals of Surgical Oncology, vol. 25 no. 2 (February, 2018), pp. 354-355 [doi]
Recent Grant Support